Neeraj Narula
@NarulaNeeraj
IBD specialist @HamHealthSci, Director of the IBD Clinic, Director of the IBD Fellowship @McMasterU
Time to stop lumping together all patients with prior biologic 'exposure'? Our latest work in #JCC @OUPAcademic found outcomes of IBD patients with prior biologic intolerance to be better than those with prior failure. academic.oup.com/ecco-jcc/advan…
Our latest work in @IBDJournals: Validation of the MM-SES-CD to predict endoscopic healing at one year. We also found it to be predictive of clinical and calprotectin remission! academic.oup.com/ibdjournal/adv…
Preliminary Results From a Multicenter Randomized Trial Using Fecal Microbiota Transplantation to Induce Remission in Patients With Mild-to-Moderate Crohn's Disease Kao, et al. 📕bit.ly/4ebNtnY @MLongMD @JasmohanBajaj @PaulMoayyedi @RPanaccione @NarulaNeeraj @madsen_ca
Just part of the McMaster IBD team on another busy day of clinic! @NarulaNeeraj @MacDeptMed @TheCDHF @getgutsycanada
Please join us for our post ECCO 2025 IBD Update to review the top presented abstracts. Expert commentary by @vipuljairath Join Here! us02web.zoom.us/webinar/regist…
Congrats to @VerduLab for receiving King Charles III Coronation Medal for her outstanding contributions to GI and celiac research! @machealthsci #cddwclm2025
The TRIUMPH study is now published in Crohns Colitis 360 @IBDJournals. Thank you to @CIRC_CCRM for their endorsement, the investigators, and the patients for their participation. Another step to understand use of JAK inhibitors in acute severe UC! academic.oup.com/crohnscolitis3…
📢 New article on this #JCAGJeudi 📰 Acceptability, feasibility, and impact of the MyGut digital health platform in the monitoring and management of inflammatory bowel disease ✍️by Jamie Zhen, Maude Simoneau, Pooja Sharma, Pascale Germain and others 🔗academic.oup.com/jcag/article/7…
Diet can play a key role in the management of #IBD and is gaining acceptance slowly but surely Dietary options for IBD have in common: ✅ ⬆ whole foods ✅ ⬇ highly or ultraprocessed foods @AmJGastro 👇👇👇
Expect a great update and discussion from Uegw 2024 from these titans of IBD in Canada!
Join Dr. John Marshall @marshllj, Dr. Jeffrey McCurdy @GI_JeffMD, Dr. Waqqas Afif @waqqasafif and Dr. Sally Lawrence, for this IBD Update webinar highlighting selected abstracts from UEGW 2024. 👉Learn more and register: ow.ly/HkLx50U5y0o
This post-hoc analysis from EXTEND found endoscopic healing as defined by MM-SES-CD < 22.5 performs better to differentiate drug vs. placebo effects compared to SES-CD based definitions of endoscopic remission. Our latest work in #JCC @OUPAcademic academic.oup.com/ecco-jcc/advan…
Congratulations to Dr. Remo Panaccione, the 2024 Research Leadership award recipient! We’re honoured to recognize him for his accomplishments toward moving forward the search for cures! #IBDMinds2024
Congratulations to the 2024 Physician of the Year, Dr. John Marshall! 🩺! He receives this award in recognition of the impact he’s made for his patients and the quality of IBD care in Canada. #IBDMinds2024
Improved treatment outcomes were observed in #IBD patients compared to failure in clinical trials, suggesting that future trials should more rigorously differentiate prior failure from intolerance. Samnani et al. @vipuljairath @PDulaiMD @NarulaNeeraj academic.oup.com/ecco-jcc/advan…
How would you rank novel therapies such as etrasimod, risankizumab, mirikizumab, and guselkumab in UC ❓ What treatment 🎯 you are interested in ❓ Our recent NMA at @AGA_CGH cghjournal.org/article/S1542-… @TBessissow @vipuljairath @Bealoquebea @MondayNightIBD @IBDimmunology…